The Medicines Company (MDCO) financial statements (2021 and earlier)

Company profile

Business Address 8 SYLVAN WAY
PARSIPPANY, NJ 07054
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments241151542373371377570
Cash and cash equivalents238151542373371377519
Short-term investments3     51
Receivables 3225215610286
Inventory, net of allowances, customer advances and progress billings167165818776
Inventory167165818776
Disposal group, including discontinued operation 391 323   
Prepaid expense and other current assets10
Deferred tax assets    3314 
Other undisclosed current assets53121920161314
Total current assets:295563654833657591756
Noncurrent Assets
Property, plant and equipment9173135403916
Intangible assets, net (including goodwill)2012018719261,1791,094134
Goodwill20120125628928725815
Intangible assets, net (excluding goodwill)  615636893836120
Restricted cash and investments7651122
Other noncurrent assets56112815
Prepaid expense and other noncurrent assets17
Deferred tax assets, net    (165)(129) 
Other undisclosed noncurrent assets32681144 16512947
Total noncurrent assets:5473101,0519741,2291,150216
TOTAL ASSETS:8428731,7051,8071,8861,741972
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities58105117165223205157
Accounts payable1102836202725
Accrued liabilities589589129159142107
Employee-related liabilities    443524
Interest and dividends payable    0  
Debt  54258   
Disposal group, including discontinued operation 61 68   
Business combination, contingent consideration, liability 55527210
Deferred revenue and credits419201452
Other undisclosed current liabilities    (44)(35)(24)
Total current liabilities:58175245537404174135
Noncurrent Liabilities
Liabilities, other than long-term debt1391021031741366
Deferred tax liabilities, net  9090164129 
Other liabilities13912131086
Other undisclosed noncurrent liabilities793664706418387538245
Total noncurrent liabilities:806673808521562675251
Total liabilities:8648481,0521,058966849386
Temporary equity, carrying amount  117   
Stockholders' equity
Stockholders' equity attributable to parent(22)25653732921892586
Common stock0000000
Treasury stock, value(90)(90)(50)(50)(50)(50)(50)
Additional paid in capital1,4531,3771,2571,2081,045992697
Accumulated other comprehensive income (loss)(5)(5)(5)43(5)(1)
Accumulated deficit(1,381)(1,257)(549)(430)(77)(45)(60)
Stockholders' equity attributable to noncontrolling interest  (1)(0)(0)(0)(0)
Total stockholders' equity:(22)25652732920892586
TOTAL LIABILITIES AND EQUITY:8428731,7051,8071,8861,741972

Income statement (P&L) ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues64516830915559
Revenue, net45168309724688559
Cost of revenue(36)(47)(333)(120)(288)(263)(177)
Cost of goods and services sold(7)(47)(71)(120)(288)(263)(177)
Gross profit:(30)(2)(165)189(286)(258)381
Operating expenses(162)(663)(196)(462)(537)(448)(303)
Other undisclosed operating income    7597195
Operating income (loss):(191)(665)(362)(272)(65)1383
Nonoperating income (expense)(46)200(6)10
Investment income, nonoperating(52)   (8)(0)(1)
Other nonoperating income6200021
Interest and debt expense(49)(49)(50)(37)(16)(16)(8)
Other undisclosed income from continuing operations before equity method investments, income taxes    471811
Income (loss) from continuing operations before equity method investments, income taxes:(287)(712)(411)(309)(39)1786
Income (loss) from equity method investments   (0)(2)(1)3
Other undisclosed income from continuing operations before income taxes1829258   
Income (loss) from continuing operations before income taxes:(286)(704)(119)(252)(41)1589
Income tax expense (benefit)5197(0)307(1)(35)
Other undisclosed income (loss) from continuing operations    (5)3 
Income (loss) from continuing operations:(235)(608)(119)(222)(39)1754
Income (loss) from discontinued operations (101)0    
Income (loss) before gain (loss) on sale of properties:(235)(708)(119)(222)(39)1754
Other undisclosed net income (loss)112  (131)7(1)(2)
Net income (loss):(123)(708)(119)(353)(32)1651
Net income attributable to noncontrolling interest  0 000
Other undisclosed net loss attributable to parent   (0)(0)(1)(0)
Net income (loss) available to common stockholders, diluted:(123)(708)(119)(353)(32)1551

Comprehensive Income ($ in millions)

12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net income (loss):(123)(708)(119)(353)(32)1651
Other comprehensive income (loss)10(9)17(4) 
Comprehensive income (loss):(123)(708)(129)(351)(25)1251
Comprehensive income (loss), net of tax, attributable to noncontrolling interest  0(0)0(0)(0)
Other undisclosed comprehensive loss, net of tax, attributable to parent    (0) (0)
Comprehensive income (loss), net of tax, attributable to parent:(123)(708)(129)(351)(25)1151

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: